A novel designer drug first developed in the 1960's as a research chemical, MDPBP first emerged as a legal high in Europe in 2009. This synthetic cathinone and bath salt is often sold in the US and other countries under the name "NRG-1" as a mixture with other substituted cathinone derivatives such as flephedrone, pentylone, and MDPV.